Survivin is a Therapeutic Target in Ewing Sarcoma

被引：0
|
作者：
Dioufa, Nikolina [1 ]
Tsokos, Maria [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Med, Boston, MA 02215 USA
来源：
FASEB JOURNAL | 2015年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
417.6
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The epidermal growth factor receptor HER2 is not a major therapeutic target in Ewing sarcoma
    Ye, D
    Maitra, A
    Timmons, CF
    Leavey, PJ
    Ashfaq, R
    Ilaria, RL
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (06) : 459 - 466
  • [32] Characterization and evaluation of the protein kinase BUB1B as therapeutic target in ewing sarcoma
    Schaefer, C.
    Kerkhoff, M.
    Plaumann, P.
    Oender, H.
    Kuballa, M.
    Gruenewald, T.
    Potratz, J.
    Hartmann, W.
    Dirksen, U.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S158 - S158
  • [33] RNAi screening identifies STK10 as a novel therapeutic target for Ewing's sarcoma
    Arora, Shilpi
    Gonzales, Irma M.
    Sima, Chao
    Khan, Javed
    Mousses, Spyro
    Azorsa, David O.
    CANCER RESEARCH, 2010, 70
  • [34] Pregnancy associated plasma protein A (PAPP-A) is a potential novel therapeutic target in Ewing sarcoma
    Heitzeneder, Sabine
    Shern, John F.
    Khan, Javed
    Mackall, Crystal L.
    CANCER RESEARCH, 2016, 76
  • [35] ErbB4 is a new therapeutic target for metastasis and anoikis resistance in Ewing's sarcoma
    Mendoza-Naranjo, Ariadna
    Mistry, Pitri
    Lazic, Nikola
    Strauss, Sandra J.
    Sorensen, Poul H. B.
    CANCER RESEARCH, 2011, 71
  • [36] BRCA1:NRF2 pathway as a new therapeutic target in ewing sarcoma
    Bassani, Nicklas
    CLINICAL CANCER RESEARCH, 2022, 28 (18)
  • [37] High nuclear survivin expression is associated with metastatic disease in Ewing sarcoma
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 493 - 494
  • [38] Survivin as a therapeutic target in adrenocortical carcinoma
    Bussey, Kimberly
    Stephan, Elizabeth
    Wandoloski, Melissa
    DelGiorno, Kathleen
    Brabant, Marc
    Sinari, Shripad
    Mount, David
    Azorsa, David
    Trent, Jeffrey
    Von Hoff, Daniel
    Demeure, Michael
    CANCER RESEARCH, 2009, 69
  • [39] Validating survivin as a cancer therapeutic target
    Dario C. Altieri
    Nature Reviews Cancer, 2003, 3 : 46 - 54
  • [40] Validating survivin as a cancer therapeutic target
    Altieri, DC
    NATURE REVIEWS CANCER, 2003, 3 (01) : 46 - 54
12345